John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
ICL Group
ICL
$7.42B
| $3.07M | 0.01% |
338,214
+123,793
| +58% | +$1.37M |
|
952
Palomar
PLMR
$3.5B
| $3.06M | 0.01% |
47,505
-580
| -1% | -$35K |
|
|
TEN
953
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $3.04M | 0.01% |
177,156
-214,859
| -55% | -$3.63M |
|
|
KREF
954
KKR Real Estate Finance Trust
KREF
$483M
| $3.03M | 0.01% |
173,688
-158,822
| -48% | -$3.06M |
|
|
ACC
955
DELISTED
American Campus Communities, Inc.
ACC
| $3.03M | 0.01% |
+46,981
| New | +$2.98M |
|
|
VBTX
956
DELISTED
Veritex Holdings
VBTX
| $3.03M | 0.01% |
103,481
+83,683
| +423% | +$2.79M |
|
|
LAND
957
Gladstone Land Corp
LAND
$381M
| $3.02M | 0.01% |
136,339
+77,339
| +131% | +$2.34M |
|
|
SGMO
958
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.02M | 0.01% |
728,830
+368,438
| +102% | +$1.59M |
|
959
Woodward
WWD
$19.7B
| $3.02M | 0.01% |
32,617
-58,715
| -64% | -$6.11M |
|
960
Rocket Pharmaceuticals
RCKT
$388M
| $3.01M | 0.01% |
218,962
-25,688
| -10% | -$306K |
|
961
Wintrust Financial
WTFC
$10.3B
| $3.01M | 0.01% |
37,575
-1,327
| -3% | -$114K |
|
962
Viking Therapeutics
VKTX
$3.88B
| $3.01M | 0.01% |
1,042,002
-202,090
| -16% | -$500K |
|
963
Carlyle Group
CG
$17.5B
| $3M | 0.01% |
94,832
-355,432
| -79% | -$13.6M |
|
964
Rithm Capital
RITM
$5.72B
| $2.99M | 0.01% |
321,242
+153,622
| +92% | +$1.61M |
|
|
NIU
965
Niu Technologies
NIU
$152M
| $2.99M | 0.01% |
347,702
-209,137
| -38% | -$1.77M |
|
966
Magnite
MGNI
$3.38B
| $2.98M | 0.01% |
335,671
-144,954
| -30% | -$1.55M |
|
967
PNC Financial Services
PNC
$97.2B
| $2.97M | 0.01% |
+18,844
| New | +$3.16M |
|
|
BHVN
968
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.97M | 0.01% |
20,400
-136,963
| -87% | -$17.5M |
|
969
HCI Group
HCI
$2.31B
| $2.97M | 0.01% |
43,799
-3,614
| -8% | -$239K |
|
970
Angi Inc
ANGI
$200M
| $2.96M | 0.01% |
64,659
+303
| +0.5% | +$14.9K |
|
|
OBE
971
Obsidian Energy
OBE
$769M
| $2.96M | 0.01% |
381,800
+176,149
| +86% | +$1.56M |
|
972
Colliers International
CIGI
$5.51B
| $2.95M | 0.01% |
26,874
-80,132
| -75% | -$9.15M |
|
973
MGP Ingredients
MGPI
$384M
| $2.94M | 0.01% |
29,393
+26,693
| +989% | +$2.51M |
|
974
Fortis
FTS
$28.3B
| $2.94M | 0.01% |
62,150
+14,600
| +31% | +$716K |
|
975
Oramed Pharmaceuticals
ORMP
$200M
| $2.93M | 0.01% |
639,557
+88,601
| +16% | +$473K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.